EUROPE: Generics will profit from healthcare cuts
You must be signed in to read this analysis
In this article
- Pharmaco-economics
- Structural changes
- United Kingdom
- Germany
- France
- Greece
- Pharmaceutical industry
- Prices
- Generics
- Corruption
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.